Edouard Mobarak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Edouard Mobarak has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ilpo Vattulainen
Department of Physics, University of Helsinki, Helsinki, Finland
2 shared publications Tomasz Rog
Department of Physics, University of Helsinki, P. O. Box 64, FI-00014 Helsinki, Finland; Laboratory of Physics, Tampere University of Technology, P. O. Box 692, FI-33101 Tampere, Finland
2 shared publications- Tomasz Róg
Department of Physics, University of Helsinki, P.O. Box 64, FI-00014 Helsinki, Finland
2 shared publications - Agnieszka Polit
Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Gronostajowa 7, PL-30387 Krakow, Poland
1 shared publication - Alex Bunker
University of Helsinki
1 shared publication - Alf Honigmann
Technische Universität Dresden, Biotechnologisches Zentrum, Center for Molecular and Cellular Bioengineering (CMCB)
1 shared publication
Latest Publications
- 1 November 2019
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 123 (46) , 9839-9845
Cholesteryl Hemisuccinate Is Not a Good Replacement for Cholesterol in Lipid Nanodiscs
Nanodiscs are suitable tool for studies of membrane proteins (MPs) due to their ability to mimic native biological membranes and several MP structures are solved in nanodiscs. Among the various cell membrane components, cholesterol (CHL) is known to regulate protein function and their concentration can reach up to 50 mol %. However, studies comprising cholesterol is challenging due to its hydrophobic nature, hence, nanodiscs with only low cholesterol concentration has been studied. To overcome the problem, cholesterol analogs with high solubility in polar solutions are often used and one of them is cholesteryl hemisuccinate (CHS). Nevertheless, in molecular dynamics (MD) simulation, this is not an obstacle. In this study, we performed MD simulations of nanodiscs containing neutral phosphatidylcholine (POPC) lipids, negatively charged phosphatidylglycerol (POPG) lipids, CHL, or negatively charged cholesterol analog, CHS. Our simulations show that CHS increases the order of lipids in nanodiscs, the effect is however weaker than CHL, and even smaller in nanodiscs. Furthermore, CHS gathered around scaffold proteins while cholesterol was uniformly distributed in the nanodiscs. Thus, nanodiscs with CHS are heterogeneous and not equivalent to nanodiscs with CHL. Finally, we also observed the increased concentration of POPG near the scaffold proteins, driven by electrostatic interactions. The MD results are experimentally validated using electron paramagnetic resonance spectroscopy. These results show that nanodiscs are in fact, complex structures not easily comparable with planar lipid bilayers.
- 1 November 2019
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 123 (46) , 9839-9845
Cholesteryl Hemisuccinate Is Not a Good Replacement for Cholesterol in Lipid Nanodiscs
Nanodiscs are suitable tool for studies of membrane proteins (MPs) due to their ability to mimic native biological membranes and several MP structures are solved in nanodiscs. Among the various cell membrane components, cholesterol (CHL) is known to regulate protein function and their concentration can reach up to 50 mol %. However, studies comprising cholesterol is challenging due to its hydrophobic nature, hence, nanodiscs with only low cholesterol concentration has been studied. To overcome the problem, cholesterol analogs with high solubility in polar solutions are often used and one of them is cholesteryl hemisuccinate (CHS). Nevertheless, in molecular dynamics (MD) simulation, this is not an obstacle. In this study, we performed MD simulations of nanodiscs containing neutral phosphatidylcholine (POPC) lipids, negatively charged phosphatidylglycerol (POPG) lipids, CHL, or negatively charged cholesterol analog, CHS. Our simulations show that CHS increases the order of lipids in nanodiscs, the effect is however weaker than CHL, and even smaller in nanodiscs. Furthermore, CHS gathered around scaffold proteins while cholesterol was uniformly distributed in the nanodiscs. Thus, nanodiscs with CHS are heterogeneous and not equivalent to nanodiscs with CHL. Finally, we also observed the increased concentration of POPG near the scaffold proteins, driven by electrostatic interactions. The MD results are experimentally validated using electron paramagnetic resonance spectroscopy. These results show that nanodiscs are in fact, complex structures not easily comparable with planar lipid bilayers.
- Open Access
- 1 November 2018
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1860 (11) , 2436-2445
How to minimize dye-induced perturbations while studying biomembrane structure and dynamics: PEG linkers as a rational alternative
- 1 November 2018
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1860 (11) , 2436-2445
Open AccessHow to minimize dye-induced perturbations while studying biomembrane structure and dynamics: PEG linkers as a rational alternative
- Open Access
- 11 September 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-11
Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico
Toll-like receptor 4 (TLR4) is activated by bacterial lipopolysaccharide (LPS), which drives the production of proinflammatory cytokines. Earlier studies have indicated that cholesterol- and glycosphingolipid-rich subregions of the plasma membrane (lipid domains) are important for TLR4-mediated signaling. We report that inhibition of glucosylceramide (GluCer) synthase, which resulted in decreased concentrations of the glycosphingolipid GluCer in lipid domains, reduced the LPS-induced inflammatory response in both mouse and human macrophages. Atomistic molecular dynamics simulations of the TLR4 dimer complex (with and without LPS in its MD-2 binding pockets) in membranes (in the presence and absence of GluCer) showed that: (1) LPS induced a tilted orientation of TLR4 and increased dimer integrity; (2) GluCer did not affect the integrity of the LPS/TLR4 dimer but reduced the LPS-induced tilt; and (3) GluCer increased electrostatic interactions between the membrane and the TLR4 extracellular domain, which could potentially modulate the tilt. We also showed that GCS inhibition reduced the interaction between TLR4 and the intracellular adaptor protein Mal. We conclude that the GluCer-induced effects on LPS/TLR4 orientation may influence the signaling capabilities of the LPS/TLR4 complex by affecting its interaction with downstream signaling proteins.
- 11 September 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-11
Open AccessGlucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico
Toll-like receptor 4 (TLR4) is activated by bacterial lipopolysaccharide (LPS), which drives the production of proinflammatory cytokines. Earlier studies have indicated that cholesterol- and glycosphingolipid-rich subregions of the plasma membrane (lipid domains) are important for TLR4-mediated signaling. We report that inhibition of glucosylceramide (GluCer) synthase, which resulted in decreased concentrations of the glycosphingolipid GluCer in lipid domains, reduced the LPS-induced inflammatory response in both mouse and human macrophages. Atomistic molecular dynamics simulations of the TLR4 dimer complex (with and without LPS in its MD-2 binding pockets) in membranes (in the presence and absence of GluCer) showed that: (1) LPS induced a tilted orientation of TLR4 and increased dimer integrity; (2) GluCer did not affect the integrity of the LPS/TLR4 dimer but reduced the LPS-induced tilt; and (3) GluCer increased electrostatic interactions between the membrane and the TLR4 extracellular domain, which could potentially modulate the tilt. We also showed that GCS inhibition reduced the interaction between TLR4 and the intracellular adaptor protein Mal. We conclude that the GluCer-induced effects on LPS/TLR4 orientation may influence the signaling capabilities of the LPS/TLR4 complex by affecting its interaction with downstream signaling proteins.
- 8 February 2018
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 54 (28) , 3440-3443
Membrane bound COMT isoform is an interfacial enzyme: general mechanism and new drug design paradigm
The enzyme catechol-O-methyltransferase (COMT) has water soluble (S-COMT) and membrane associated (MB-COMT), bitopic, isoforms. Of these MB-COMT is a drug target in relation to the treatment of Parkinson's disease. Using a combination of computational and experimental protocols, we have determined the substrate selection mechanism specific to MB-COMT. We show: (1) substrates with preferred affinity for MB-COMT over S-COMT orient in the membrane in a fashion conducive to catalysis from the membrane surface and (2) binding of COMT to its cofactor ADOMET induces conformational change that drives the catalytic surface of the protein to the membrane surface, where the substrates and Mg2+ ions, required for catalysis, are found. Bioinformatics analysis reveals evidence of this mechanism in other proteins, including several existing drug targets. The development of new COMT inhibitors with preferential affinity for MB-COMT over S-COMT is now possible and insight of broader relevance, into the function of bitopic enzymes, is provided.
- 8 February 2018
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 54 (28) , 3440-3443
Membrane bound COMT isoform is an interfacial enzyme: general mechanism and new drug design paradigm
The enzyme catechol-O-methyltransferase (COMT) has water soluble (S-COMT) and membrane associated (MB-COMT), bitopic, isoforms. Of these MB-COMT is a drug target in relation to the treatment of Parkinson's disease. Using a combination of computational and experimental protocols, we have determined the substrate selection mechanism specific to MB-COMT. We show: (1) substrates with preferred affinity for MB-COMT over S-COMT orient in the membrane in a fashion conducive to catalysis from the membrane surface and (2) binding of COMT to its cofactor ADOMET induces conformational change that drives the catalytic surface of the protein to the membrane surface, where the substrates and Mg2+ ions, required for catalysis, are found. Bioinformatics analysis reveals evidence of this mechanism in other proteins, including several existing drug targets. The development of new COMT inhibitors with preferential affinity for MB-COMT over S-COMT is now possible and insight of broader relevance, into the function of bitopic enzymes, is provided.